Key statistics
On Monday, Rallybio Corp (RLYB:NSQ) closed at 1.13, 4.63% above its 52-week low of 1.08, set on Sep 10, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 1.14 |
---|---|
High | 1.14 |
Low | 1.11 |
Bid | 1.12 |
Offer | 1.17 |
Previous close | 1.11 |
Average volume | 45.15k |
---|---|
Shares outstanding | 41.49m |
Free float | 36.75m |
P/E (TTM) | -- |
Market cap | 46.88m USD |
EPS (TTM) | -1.79 USD |
Data delayed at least 15 minutes, as of Oct 07 2024 21:00 BST.
More ▼
Press releases
- Data Demonstrating ENPP1 Inhibition as a Therapeutic Approach for Later-onset Hypophosphatasia Presented at the American Society for Bone and Mineral Research 2024 Annual Meeting
- Rallybio to Present Results of Epidemiological Analysis Demonstrating FNAIT Risk Across Racially and Ethnically Diverse Populations at the American Society of Human Genetics 2024 Annual Meeting
- Rallybio to Present Results of Epidemiological Analysis Demonstrating FNAIT Risk Across Racially and Ethnically Diverse Populations at the NORD Breakthrough Summit
- Fierce Names Rallybio to the 2024 Fierce 50 List as an Innovation Honoree
- Rallybio Announces Publication of RLYB212 Phase 1 Proof-of-Concept Study Results in Thrombosis and Haemostasis
- Rallybio to Present at Upcoming Investor Conferences
- Rallybio Reports Second Quarter 2024 Financial Results and Provides Business Updates
More ▼